603
Views
7
CrossRef citations to date
0
Altmetric
REVIEW

An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment

, , , , , & show all
Pages 765-779 | Received 25 Oct 2022, Accepted 29 Jan 2023, Published online: 14 Feb 2023

Figures & data

Figure 1 Pathogenesis of sepsis-related liver injury and drug delivery nanosystems.

Figure 1 Pathogenesis of sepsis-related liver injury and drug delivery nanosystems.

Figure 2 Mechanism of DOX-hyd-BSA NPs targeting pro-inflammatory neutrophils to induce their apoptosis for the treatment of septic inflammation. (A) The therapeutic mechanism of DOX-hyd-BSA NPs; (B) The preparation route of DOX-conjugated BSA NPs.

Notes: Reprinted from Zhang CY, Dong X, Gao J, Lin W, Liu Z, Wang Z. Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke. Sci Adv. 2019;5(11):eaax7964. https://creativecommons.org/licenses/by-nc/4.0/.Citation34
Figure 2 Mechanism of DOX-hyd-BSA NPs targeting pro-inflammatory neutrophils to induce their apoptosis for the treatment of septic inflammation. (A) The therapeutic mechanism of DOX-hyd-BSA NPs; (B) The preparation route of DOX-conjugated BSA NPs.

Figure 3 Scheme for designing IME responsive and biofunctional nanoparticles (NPs) and for targeted delivery of nanotherapeutics at the site of infection. (A) The designing strategy of intercellular adhesion molecule-1 antibodies-modified multifunctional NPs; (B) The prepared NPs showed a preferential accumulation at a site of infection by interaction with intercellular adhesion molecule-1.

Notes: Reprinted with permission from John Wiley and Sons. Zhang CY, Gao J, Wang Z. Bioresponsive nanoparticles targeted to infectious microenvironments for sepsis management. Adv Mater. 2018;30(43):e1803618. © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.Citation55
Figure 3 Scheme for designing IME responsive and biofunctional nanoparticles (NPs) and for targeted delivery of nanotherapeutics at the site of infection. (A) The designing strategy of intercellular adhesion molecule-1 antibodies-modified multifunctional NPs; (B) The prepared NPs showed a preferential accumulation at a site of infection by interaction with intercellular adhesion molecule-1.

Table 1 Antioxidant Nanodrug Delivery System with Potential to Alleviate Liver Injury in Sepsis

Figure 4 Preparation and efficacy assessment of PEG-HNPs for sepsis treatment.

Notes: Reprinted from Koide H, Okishima A, Hoshino Y, et al. Synthetic hydrogel nanoparticles for sepsis therapy. Nat Commun. 2021;12(1):5552. https://creativecommons.org/licenses/by/4.0/.Citation44
Figure 4 Preparation and efficacy assessment of PEG-HNPs for sepsis treatment.

Table 2 Summary of Drug Delivery Nanosystems for Bacterial Translocation in SRIL